Minorsol (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calcium Chloride Dihydrate, Glu)

• Minorsol is an intravenous electrolyte solution used in clinical situations that require rapid restoration of fluid and electrolyte balance.
• Electrolyte replacement: restores magnesium, potassium, sodium, calcium and glucose levels in patients with deficits.
• Fluid resuscitation: provides essential volume to support circulatory stability in hypovolemic states.
• Maintenance of electrolyte balance: sustains normal plasma electrolyte concentrations during ongoing therapy or surgery.

• The solution delivers magnesium, potassium, sodium, calcium ions and glucose directly into the bloodstream. These electrolytes participate in cellular osmotic regulation, nerve impulse transmission, muscle contraction and acid‑base balance. Intravenous administration bypasses gastrointestinal absorption, allowing immediate correction of plasma deficits and rapid expansion of intravascular volume, thereby supporting hemodynamic stability and metabolic needs. The glucose component also supplies immediate energy to cells during acute treatment.

Adverse reactions to Minorsol may vary in frequency and severity.

Common Side Effects

• Injection site pain: mild discomfort or tenderness at the infusion site.
• Transient hypermagnesemia: temporary elevation of serum magnesium causing mild flushing.
• Hyperkalemia: mild increase in serum potassium, often asymptomatic.
• Hypocalcemia: occasional drop in calcium levels leading to tingling sensations.
• Nausea: brief feeling of queasiness after infusion.
• Headache: mild headache reported by some patients.

Serious or Rare Side Effects

• Severe hypermagnesemia: can cause respiratory depression, hypotension, or cardiac arrhythmias.
• Anaphylactic reaction: rare but possible hypersensitivity with rash, bronchospasm, or shock.
• Severe hyperkalemia: risk of life‑threatening cardiac arrhythmias.
• Local thrombophlebitis: inflammation and clot formation at the injection site.
• Electrolyte imbalance: significant shifts leading to seizures or muscle weakness.

Before using Minorsol, clinicians should consider several precautionary measures to ensure safe administration.

• Renal function: assess kidney performance, as impaired excretion may increase electrolyte levels.
• Cardiac status: monitor patients with heart disease for arrhythmias due to electrolyte shifts.
• Serum electrolytes: obtain baseline magnesium, potassium, calcium and sodium values.
• Infusion rate: administer slowly to avoid rapid electrolyte changes.
• Allergy history: verify no known hypersensitivity to any component.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Minorsol can interact with other medications that affect electrolyte balance or cardiac conduction.

Major Interactions (Avoid)

• Calcium channel blockers: may potentiate hypotensive effects when combined with rapid fluid shifts.
• Digoxin: elevated potassium can increase risk of digoxin toxicity.
• Loop diuretics: concurrent use may cause excessive electrolyte loss if not monitored.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: monitor potassium levels to avoid hyperkalemia.
• Beta‑blockers: watch for additive effects on heart rate and blood pressure.
• Insulin therapy: glucose infusion may require insulin dose adjustment.